Essity AB (ETTYF) is a leading global hygiene and health company with strong brands in tissue, personal care, and incontinence products. Despite recent margin pressures from input cost inflation, the company is executing a comprehensive restructuring program that is expected to deliver significant cost savings and margin expansion over the next 12 months. With a robust balance sheet, high free cash flow generation, and a defensive consumer staple profile, Essity offers an attractive risk-reward for long-term investors.
Investment Thesis
Essity is a classic consumer compounder benefiting from secular trends in hygiene awareness, aging populations, and premiumization in emerging markets. The company’s focus on innovation and sustainability positions it well for consistent growth. The current valuation, depressed by temporary headwinds, provides an entry point for investors to capture margin recovery and multiple expansion.
12-Month Catalysts
- Restructuring program delivering €1.5 billion in annual savings by 2025, boosting EBIT margins by 200-300 bps.
- Easing pulp and energy costs improving input cost environment, supporting margin recovery.
- Strong free cash flow yield of ~7% allowing for debt reduction and increased shareholder returns.
Key Risks
- Commodity price volatility, particularly pulp and energy, could delay margin recovery.
- Intense competition in the tissue market may limit pricing power.
Disclaimer: This is not financial advice. Please conduct your own research or consult a financial advisor before investing.